• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于80 kDa人精子抗原(80 kDa HSA)合成肽的研究。

Studies with Synthetic Peptides of 80 kDa Human Sperm Antigen (80 kDa HSA).

作者信息

Vernekar Vandana J, Bandivdekar A H, Raghavan Vijaya P, Kamada M, Koide S S

机构信息

National Institute for Research, in Reproductive Health, J. M. Street, Parel, Mumbai, India.

出版信息

Am J Reprod Immunol. 2004 Feb;51(2):106-11. doi: 10.1111/j.1600-0897.2004.00109.x.

DOI:10.1111/j.1600-0897.2004.00109.x
PMID:14748835
Abstract

PROBLEM

The 80 kDa human sperm antigen (HSA) is a sperm-specific and conserved antigen, capable of inducing immunological infertility. Partial N-terminal amino acid sequences of 80 kDa HSA (Peptide NT) and its peptides obtained by digestion with endoproteinase Lys-C (peptides 1-4) and endoproteinase Glu-C (peptides 5-6) did not show any sequence homology with reported known proteins deposited in the Gen-Bank. These sequenced peptides were synthesized and conjugated to key hole limpet haemocyanin (KLH) and evaluated for its antifertility effects. The present communication describes the characterization of these peptides and their antibodies.

METHOD OF STUDY

Peptides NT, 1, 2, 3 and 4 were synthesized and conjugated to KLH. Antibodies to KLH conjugated peptides were raised in rabbits by active immunization and the antibody titer was determined by enzyme-linked immunosorbent assay (ELISA) using sperm extract coated wells. The binding specificity of the synthetic peptides or purified 80 kDa HSA to their antibodies was assessed in the presence of various doses of respective synthetic peptides or 80 kDa HSA. The binding specificity was further confirmed by Western blot analysis. Antipeptide antibodies were also checked for sperm agglutinating activity, in-vitro.

RESULTS

Active immunization of rabbits elicited significant antibody titers against the synthetic peptides, except for peptide 3. Antipeptide antibodies specifically recognized the native protein in an ELISA and induced in-vitro agglutination of human, rat and monkey sperm. In addition, Western blot analysis showed that these antipeptide antibodies specifically bind to the 80 kDa HSA band of the sperm extract.

CONCLUSION

Synthetic peptides of 80 kDa HSA are immunogenic and antibodies raised against these peptides recognize the native protein detected by ELISA, Western blot analysis. In addition, they possess sperm agglutinating activity. These findings suggest that they are promising candidates in the development of immunocontraceptives.

摘要

问题

80 kDa人精子抗原(HSA)是一种精子特异性且保守的抗原,能够诱发免疫性不育。80 kDa HSA的部分N端氨基酸序列(肽段NT)以及通过内肽酶Lys-C消化获得的其肽段(肽段1 - 4)和内肽酶Glu-C消化获得的肽段(肽段5 - 6)与基因库中已报道的已知蛋白质均无序列同源性。合成这些测序的肽段并将其与钥孔血蓝蛋白(KLH)偶联,评估其抗生育作用。本通讯描述了这些肽段及其抗体的特性。

研究方法

合成肽段NT、1、2、3和4并与KLH偶联。通过主动免疫在兔体内产生针对KLH偶联肽段的抗体,使用包被有精子提取物的微孔板通过酶联免疫吸附测定(ELISA)测定抗体效价。在存在不同剂量的相应合成肽段或80 kDa HSA的情况下,评估合成肽段或纯化的80 kDa HSA与其抗体的结合特异性。通过蛋白质印迹分析进一步确认结合特异性。还在体外检查抗肽抗体的精子凝集活性。

结果

除肽段3外,兔的主动免疫产生了针对合成肽段的显著抗体效价。抗肽抗体在ELISA中特异性识别天然蛋白,并诱导人、大鼠和猴精子的体外凝集。此外,蛋白质印迹分析表明这些抗肽抗体特异性结合精子提取物的80 kDa HSA条带。

结论

80 kDa HSA的合成肽段具有免疫原性,针对这些肽段产生的抗体可通过ELISA、蛋白质印迹分析识别天然蛋白。此外,它们具有精子凝集活性。这些发现表明它们是免疫避孕药物开发中有前景的候选物。

相似文献

1
Studies with Synthetic Peptides of 80 kDa Human Sperm Antigen (80 kDa HSA).关于80 kDa人精子抗原(80 kDa HSA)合成肽的研究。
Am J Reprod Immunol. 2004 Feb;51(2):106-11. doi: 10.1111/j.1600-0897.2004.00109.x.
2
Antifertility effect of passive administration of antibodies to 80 kDa human sperm antigen and its synthetic peptides in male and female rats.被动给予抗80 kDa人精子抗原抗体及其合成肽对雄性和雌性大鼠的抗生育作用。
Am J Reprod Immunol. 2005 Dec;54(6):332-41. doi: 10.1111/j.1600-0897.2005.00309.x.
3
Characterization of 80 kDa human sperm antigen responsible for immunoinfertility.
Am J Reprod Immunol. 2001 Jan;45(1):28-34. doi: 10.1111/j.8755-8920.2001.450105.x.
4
Development of antifertility vaccine using sperm specific proteins.利用精子特异性蛋白开发抗生育疫苗。
Indian J Med Res. 2014 Nov;140 Suppl(Suppl 1):S73-7.
5
Partial amino acid sequencing of 80-kDa human sperm antigen (80-kDa HSA).
Arch Androl. 2001 Nov-Dec;47(3):227-33. doi: 10.1080/014850101753145942.
6
Screening of an antigen target for immunocontraceptives from cross-reactive antigens between human sperm and Ureaplasma urealyticum.从人精子与解脲脲原体之间的交叉反应抗原中筛选免疫避孕抗原靶点。
Infect Immun. 2007 Apr;75(4):2004-11. doi: 10.1128/IAI.01171-06. Epub 2007 Feb 5.
7
Antibody Production with Synthetic Peptides.用合成肽生产抗体。
Methods Mol Biol. 2016;1474:25-47. doi: 10.1007/978-1-4939-6352-2_2.
8
Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes.用于可靠且特异性地将抗体靶向细胞色素P450酶C末端的短合成肽。
Biochem Pharmacol. 1995 Jan 6;49(1):39-47. doi: 10.1016/0006-2952(94)00395-3.
9
Testis-specific antigen (TSA-1) is expressed in murine sperm and its antibodies inhibit fertilization.睾丸特异性抗原(TSA-1)在小鼠精子中表达,其抗体可抑制受精。
Am J Reprod Immunol. 2002 Jan;47(1):38-45. doi: 10.1034/j.1600-0897.2002.1o034.x.
10
Epitope analysis of a sperm acrosomal antigen defined by HSA-5 monoclonal antibody.
J Reprod Immunol. 1995 Oct;29(3):223-38. doi: 10.1016/0165-0378(95)00947-j.

引用本文的文献

1
Preliminary study on designing the binder of sperm-1 synthetic vaccine using sequence-based methods and molecular docking.基于序列方法和分子对接设计精子-1合成疫苗佐剂的初步研究
J Adv Vet Anim Res. 2022 Mar 10;9(1):122-127. doi: 10.5455/javar.2022.i576. eCollection 2022 Mar.
2
Evaluation of cystatin C activities against HIV.评估胱抑素C对HIV的活性。
Indian J Med Res. 2015 Apr;141(4):423-30. doi: 10.4103/0971-5916.159282.
3
Development of antifertility vaccine using sperm specific proteins.利用精子特异性蛋白开发抗生育疫苗。
Indian J Med Res. 2014 Nov;140 Suppl(Suppl 1):S73-7.
4
High quality sperm for nonhuman primate ART: production and assessment.用于非人灵长类动物辅助生殖技术的高质量精子:生产与评估
Reprod Biol Endocrinol. 2004 Jun 16;2:33. doi: 10.1186/1477-7827-2-33.